136 related articles for article (PubMed ID: 23064049)
21. Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1-siRNA.
Kantara C; O'Connell M; Sarkar S; Moya S; Ullrich R; Singh P
Cancer Res; 2014 May; 74(9):2487-98. PubMed ID: 24626093
[TBL] [Abstract][Full Text] [Related]
22. Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells.
Wu S; Wang X; Chen J; Chen Y
Biochem Biophys Res Commun; 2013 May; 434(4):898-903. PubMed ID: 23624503
[TBL] [Abstract][Full Text] [Related]
23. DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells.
Spada F; Haemmer A; Kuch D; Rothbauer U; Schermelleh L; Kremmer E; Carell T; Längst G; Leonhardt H
J Cell Biol; 2007 Feb; 176(5):565-71. PubMed ID: 17312023
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27.
Yasuda K; Hirohashi Y; Mariya T; Murai A; Tabuchi Y; Kuroda T; Kusumoto H; Takaya A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Hirano H; Hasegawa T; Saito T; Sato N; Torigoe T
Oncotarget; 2017 May; 8(19):31540-31553. PubMed ID: 28415561
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-12 inhibits the survival of human colon cancer stem cells in vitro and their tumor initiating capacity in mice.
Yin XL; Wang N; Wei X; Xie GF; Li JJ; Liang HJ
Cancer Lett; 2012 Sep; 322(1):92-7. PubMed ID: 22366581
[TBL] [Abstract][Full Text] [Related]
26. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
27. LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells.
Wang L; Hirohashi Y; Ogawa T; Shen M; Takeda R; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
Biochem Biophys Res Commun; 2017 Apr; 486(2):232-238. PubMed ID: 28238780
[TBL] [Abstract][Full Text] [Related]
28. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
[TBL] [Abstract][Full Text] [Related]
29. Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers.
Grotenhuis BA; Dinjens WN; Wijnhoven BP; Sonneveld P; Sacchetti A; Franken PF; van Dekken H; Tilanus HW; van Lanschot JJ; Fodde R
J Pathol; 2010 Aug; 221(4):379-89. PubMed ID: 20549647
[TBL] [Abstract][Full Text] [Related]
30. Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene.
Yamada R; Takahashi A; Torigoe T; Morita R; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Watarai K; Kondo T; Hirohashi Y; Sato N
Tissue Antigens; 2013 Jun; 81(6):428-34. PubMed ID: 23574628
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.
Zhang H; Li W; Nan F; Ren F; Wang H; Xu Y; Zhang F
Biochem Biophys Res Commun; 2011 Jan; 404(1):273-8. PubMed ID: 21130073
[TBL] [Abstract][Full Text] [Related]
32. Dnajb8, a Member of the Heat Shock Protein 40 Family Has a Role in the Tumor Initiation and Resistance to Docetaxel but Is Dispensable for Stress Response.
Yamashita M; Hirohashi Y; Torigoe T; Kusumoto H; Murai A; Imagawa T; Sato N
PLoS One; 2016; 11(1):e0146501. PubMed ID: 26751205
[TBL] [Abstract][Full Text] [Related]
33. Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population.
Mori T; Nishizawa S; Hirohashi Y; Torigoe T; Tamura Y; Takahashi A; Kochin V; Fujii R; Kondo T; Greene MI; Hara I; Sato N
Exp Mol Pathol; 2012 Feb; 92(1):27-32. PubMed ID: 22001602
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of DNA methyltransferase 1 expression in bovine fibroblast cells used for nuclear transfer.
Giraldo AM; Lynn JW; Purpera MN; Vaught TD; Ayares DL; Godke RA; Bondioli KR
Reprod Fertil Dev; 2009; 21(6):785-95. PubMed ID: 19567221
[TBL] [Abstract][Full Text] [Related]
35. Identification of cancer stem cell markers in human malignant mesothelioma cells.
Ghani FI; Yamazaki H; Iwata S; Okamoto T; Aoe K; Okabe K; Mimura Y; Fujimoto N; Kishimoto T; Yamada T; Xu CW; Morimoto C
Biochem Biophys Res Commun; 2011 Jan; 404(2):735-42. PubMed ID: 21163253
[TBL] [Abstract][Full Text] [Related]
36. ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21.
O'Brien CA; Kreso A; Ryan P; Hermans KG; Gibson L; Wang Y; Tsatsanis A; Gallinger S; Dick JE
Cancer Cell; 2012 Jun; 21(6):777-92. PubMed ID: 22698403
[TBL] [Abstract][Full Text] [Related]
37. An adoptive T cell immunotherapy targeting cancer stem cells in a colon cancer model.
Gao XY; Wang XL
J BUON; 2015; 20(6):1456-63. PubMed ID: 26854441
[TBL] [Abstract][Full Text] [Related]
38. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
39. [Effects of down-regulation of IGF2 gene on the biological characteristics of HCT116 colon cancer stem cells].
Zhao X; Li J; Liu HQ; Liu XL
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):580-586. PubMed ID: 31434448
[No Abstract] [Full Text] [Related]
40. NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer.
Sikandar SS; Pate KT; Anderson S; Dizon D; Edwards RA; Waterman ML; Lipkin SM
Cancer Res; 2010 Feb; 70(4):1469-78. PubMed ID: 20145124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]